My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 100

1.

Cationic nanoparticles for delivery of amphotericin B: preparation, characterization and activity in vitro.

Vieira DB, Carmona-Ribeiro AM.

J Nanobiotechnology. 2008 May 7;6:6.PMID: 18462496 [PubMed - in process]Related articlesFree article

2.

Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole.

Lincopan N, Carmona-Ribeiro AM.

J Antimicrob Chemother. 2006 Jul;58(1):66-75. Epub 2006 Apr 24.PMID: 16636081 [PubMed - indexed for MEDLINE]Related articlesFree article

3.

Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.

Jung SH, Lim DH, Jung SH, Lee JE, Jeong KS, Seong H, Shin BC.

Eur J Pharm Sci. 2009 Jun 28;37(3-4):313-20. Epub 2009 Mar 13.PMID: 19491021 [PubMed - indexed for MEDLINE]Related articles

4.

Colloid stability of lipid/polyelectrolyte decorated latex.

Correia FM, Petri DF, Carmona-Ribeiro AM.

Langmuir. 2004 Oct 26;20(22):9535-40.PMID: 15491183 [PubMed - indexed for MEDLINE]Related articles

5.

Development and characterization of oral lipid-based Amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans.

Wasan EK, Bartlett K, Gershkovich P, Sivak O, Banno B, Wong Z, Gagnon J, Gates B, Leon CG, Wasan KM.

Int J Pharm. 2009 May 8;372(1-2):76-84. Epub 2009 Jan 17.PMID: 19236839 [PubMed - in process]Related articles

6.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.PMID: 19275278 [PubMed - indexed for MEDLINE]Related articles

7.

Colloid stability of sodium dihexadecyl phosphate/poly(diallyldimethylammonium chloride) decorated latex.

Araujo FP, Petri DF, Carmona-Ribeiro AM.

Langmuir. 2005 Oct 11;21(21):9495-501.PMID: 16207027 [PubMed]Related articles

8.

Assembly of a model hydrophobic drug into cationic bilayer fragments.

Vieira DB, Pacheco LF, Carmona-Ribeiro AM.

J Colloid Interface Sci. 2006 Jan 1;293(1):240-7. Epub 2005 Aug 10.PMID: 16095603 [PubMed - indexed for MEDLINE]Related articles

9.

Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo.

Lincopan N, Espíndola NM, Vaz AJ, da Costa MH, Faquim-Mauro E, Carmona-Ribeiro AM.

Vaccine. 2009 Sep 25;27(42):5760-71. Epub 2009 Aug 5.PMID: 19664738 [PubMed - indexed for MEDLINE]Related articles

10.

Interactions between Bacteriophage DNA and Cationic Biomimetic Particles.

Rosa H, Petri DF, Carmona-Ribeiro AM.

J Phys Chem B. 2008 Dec 2. [Epub ahead of print]PMID: 19053669 [PubMed - as supplied by publisher]Related articles

11.

Interactions between bacteriophage DNA and cationic biomimetic particles.

Rosa H, Petri DF, Carmona-Ribeiro AM.

J Phys Chem B. 2008 Dec 25;112(51):16422-30.PMID: 19367939 [PubMed - indexed for MEDLINE]Related articles

12.

Silica-based cationic bilayers as immunoadjuvants.

Lincopan N, Santana MR, Faquim-Mauro E, da Costa MH, Carmona-Ribeiro AM.

BMC Biotechnol. 2009 Jan 19;9:5.PMID: 19152701 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.

An M, Shen H, Cao Y, Zhang J, Cai Y, Wang R, Jiang Y.

Int J Antimicrob Agents. 2009 Mar;33(3):258-63. Epub 2008 Dec 17.PMID: 19095412 [PubMed - indexed for MEDLINE]Related articles

15.

Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.

Bhaskar K, Krishna Mohan C, Lingam M, Jagan Mohan S, Venkateswarlu V, Madhusudan Rao Y, Bhaskar K, Anbu J, Ravichandran V.

Drug Dev Ind Pharm. 2009 Jan;35(1):98-113.PMID: 18665979 [PubMed - indexed for MEDLINE]Related articles

16.

Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.

Wang JJ, Liu KS, Sung KC, Tsai CY, Fang JY.

Eur J Pharm Sci. 2009 Sep 10;38(2):138-46. Epub 2009 Jul 8.PMID: 19591929 [PubMed - indexed for MEDLINE]Related articles

17.

Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.

Tobudic S, Lassnigg A, Kratzer C, Graninger W, Presterl E.

Mycoses. 2009 Feb 26. [Epub ahead of print]PMID: 19298353 [PubMed - as supplied by publisher]Related articles

18.

Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome.

Atkinson BJ, Lewis RE, Kontoyiannis DP.

Med Mycol. 2008 Sep;46(6):541-6.PMID: 19180749 [PubMed - indexed for MEDLINE]Related articles

19.

Cationic nano-copolymers mediated IKKbeta targeting siRNA inhibit the proliferation of human Tenon's capsule fibroblasts in vitro.

Duan Y, Guan X, Ge J, Quan D, Zhuo Y, Ye H, Shao T.

Mol Vis. 2008;14:2616-28. Epub 2008 Dec 31.PMID: 19137061 [PubMed - indexed for MEDLINE]Related articlesFree article

20.

In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms.

Miceli MH, Bernardo SM, Lee SA.

Int J Antimicrob Agents. 2009 Oct;34(4):326-32. Epub 2009 Jun 9.PMID: 19515537 [PubMed - indexed for MEDLINE]Related articles

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Write to the Help Desk